Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocksSAILIFE
resources
SAILIFE

Sai Life Sciences Ltd.

NSE: SAILIFE
BSE: 544306
Sector: Healthcare
Industry: Pharmaceuticals
1,257.30+19.3 (+1.56%)
3 Jul, 3:30 PM

Annual Reports and Financial Documents

Sai Life Sciences Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
202420252026
Annual Reports—FY 2025—
Quarterly Results
Conference Calls—
Presentations—

Corporate Announcements and Regulatory Filings

Sai Life Sciences Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Board Meeting1 Jul 2026
    Board Meeting Intimation for Notice Of Board Meeting
    Sai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Un-audited Financial Results ....
  • Closure of Trading Window25 Jun 2026
    Closure of Trading Window
    Trading Window Closure Intimation
  • Allotment of Equity Shares22 Jun 2026
    Announcement under Regulation 30 (LODR)-Allotment
    Allotment of 1,70,501 Equity Shares under ESOP schemes of the Company.
  • Analyst / Investor Meet10 Jun 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Analyst/Investor Meet on 11 June 2026 at Hyderabad
  • Analyst / Investor Meet27 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of schedule of meeting with analyst / Investor on 3rd and 4th June 2026 at Mumbai.
  • Newspaper Publication16 May 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication for the Audited Financial Results for the quarter and year ended 31 March 2026.
  • Analyst / Investor Meet15 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Recording of Earnings Call for the Audited Financial Results for the quarter and year ended 31 March 2026.
  • Allotment of ESOP / ESPS15 May 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Allotment of 92,000 Equity Shares under ESOP Schemes of the Company.
  • Monitoring Agency Report15 May 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    Monitoring Agency Report for the quarter and year ended 31 March 2026.
  • General14 May 2026
    Disclosure Of Key Performance Indicators Under SEBI (Issue Of Capital And Disclosure Requirements) Regulations, 2018
    Please refer to the attached intimation.
  • General14 May 2026
    Disclosure Of Key Performance Indicators Under SEBI (Issue Of Capital And Disclosure Requirements) Regulations, 2018
    Please refer to the attached intimation.
  • Press Release / Media Release14 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release for the Financial Results for the quarter and year ended 31 March 2026.
  • Outcome of Board Meeting14 May 2026
    Board Meeting Outcome for Board Meeting Outcome For Approval Of Audited Financial Results For The Financial Year Ending 31.03.2026
    Considered and Approved the Audited Financial Results for the Financial Year ended 31st March, 2026.
  • Press Release / Media Release11 May 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Intimation for Achievement of 100% renewal Power at Bidar Campus of the Company.
  • Analyst / Investor Meet11 May 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Earnings conference call invite for the quarter and year ended Financial Results ended on 31 March, 2026
  • General30 Apr 2026
    Intimation Of An Order Dated 29Th April 2026 Issued By The Joint Commissioner Of Commercial Taxes (Appeals), Kalaburagi U/S 107 (11) Of The Central Goods And Services Tax Act, 2017 And The Karnataka Goods And Services Tax Act, 2017.
    Please refer to the enclosed intimation.
  • Allotment of ESOP / ESPS23 Apr 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Allotment of 2,44,281 Equity Shares under ESOP Schemes of the Company.
  • Board Meeting21 Apr 2026
    Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone & Consolidated) For The Fourth Quarter And Year Ended 31 March 2026.
    Sai Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20188 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Please refer to the enclosed Intimation.
  • Change in Management30 Mar 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Appointment of Dr. John Pavey, Head-Global PR&D as Senior Management Personnel of the Company w.e.f. 1 April, 2026 and retirement of Dr. Dean David Edney effective from the close of business ....

Frequently Asked Questions

Where can I download the annual report of Sai Life Sciences Ltd.?
Annual reports of Sai Life Sciences Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Sai Life Sciences Ltd.?
Quarterly earnings results and presentations of Sai Life Sciences Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Sai Life Sciences Ltd. publish earnings call transcripts?
Earnings call transcripts of Sai Life Sciences Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Sai Life Sciences Ltd.?
Investor presentations and annual day presentations of Sai Life Sciences Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Sai Life Sciences Ltd.?
Corporate announcements and regulatory filings of Sai Life Sciences Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Sai Life Sciences Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sai Life Sciences Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Sai Life Sciences Ltd.?
The ISIN (International Securities Identification Number) of Sai Life Sciences Ltd. is INE570L01029. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Sai Life Sciences Ltd. listed?
Sai Life Sciences Ltd. is listed on NSE and BSE. The NSE symbol is SAILIFE and the BSE code is -.
Where can I find the shareholding pattern of Sai Life Sciences Ltd.?
The quarterly shareholding pattern of Sai Life Sciences Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Sai Life Sciences Ltd. on Sharpely?
Share price data for Sai Life Sciences Ltd. is updated as of 3 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.